Monocytosis in myelofibrosis is associated with clinical outcome, hematologic abnormalities and somatic mutations

Myelofibrosis is a chronic myeloproliferative neoplasm that has a heterogenous clinical phenotype and prognosis. Current prognostic models use a variety of clinical and laboratory characteristics to define risk groups whose median survivals can differ by nearly a decade. Prior investigations have suggested a negative prognostic role of absolute monocytosis in this disease.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research